Centre Hospitalier Universitaire Amiens Picardie
Amiens, France
Rare diseases
Investigational molecules
Locations
A plain-language summary of the goals, design and what participants do
This study involves patients who are having scheduled surgery to remove part of the colon or rectum due to colorectal cancer using a laparoscopic approach, which means the surgery is done through small incisions using a camera and specialized instruments. The study will use two different pain relief medications during and after the surgery: lidocaine, which will be given through a vein during the operation, and ropivacaine, which will be injected into the areas where the surgical instruments are inserted. In addition to these two main medications, patients may receive other medications commonly used during and after surgery to manage pain and support recovery, including nefopam, dexamethasone, paracetamol, sufentanil, parecoxib, celecoxib, morphine sulfate, propofol, and ketamine.
The purpose of this study is to evaluate how well the combination of intravenous lidocaine and ropivacaine infiltration at the surgical sites helps patients recover after their colorectal surgery. Recovery will be measured using a questionnaire called the QOR-15, which assesses how well patients are doing twenty-four hours after their operation. The study will also examine whether these medications reach levels in the blood that could cause unwanted effects, and will look for any signs of medication-related problems in the first two hours after surgery. Pain levels will be measured at different times using a numbering system where patients rate their pain, both when resting and when moving.
During the study, patients will be monitored for various aspects of their recovery over a period that extends to three months after surgery. This includes tracking how much pain medication they need, when their digestive system starts working normally again, whether they experience any unusual sensations around the surgical area, and whether they develop any nerve-related pain. The study will also record any medical or surgical complications that occur, whether patients are able to start chemotherapy if needed within two months after surgery, how long patients stay in the hospital, and how satisfied patients are with their care when they leave the hospital. Blood samples will be taken to measure the levels of lidocaine and ropivacaine in the bloodstream.
The trial runs in 11 steps – from screening to follow-up. Each step says what happens and what the team monitors.
5 criteria
3 criteria
Tell us about your condition – we search every trial in Europe and connect you with the right site.
We usually reply within a few days
All sites with verified contact details – recruitment status may not be available; ask directly
Amiens, France
Where you can join this trial
Countries are shaded by recruitment status. Click a recruiting country to ask about joining there.
RecruitingJoining a clinical trial can seem overwhelming. We guide you step by step, so you know exactly what to expect and how we support you through the process.
is a medication that blocks pain signals. In this study, it will be given through a vein (intravenously) to help reduce pain and improve recovery after surgery.
is a local anesthetic medication that numbs a specific area of the body. In this study, it will be injected into the sites where surgical instruments were inserted during the laparoscopic surgery to help control pain after the operation.
Lidocaine is a local anesthetic medication that can be given through injection into tissues or administered directly into the bloodstream through an intravenous line. It works by temporarily blocking sodium channels in nerve cells, which prevents pain signals from being transmitted to the brain. In this clinical trial, lidocaine is being studied as an intravenous treatment to help improve recovery after bowel cancer surgery performed through small incisions. This medication is well-established in medical practice and is commonly used for pain control during and after various surgical procedures.
Ropivacaine is a local anesthetic medication that is injected directly into tissues at surgical sites to provide pain relief in specific areas of the body. Similar to lidocaine, it blocks sodium channels in nerve fibers, preventing pain signals from reaching the brain, but it has a longer-lasting effect. In this study, ropivacaine is being applied by infiltration at the sites where surgical instruments are inserted during minimally invasive bowel cancer surgery. This medication is widely used in modern surgical practice and is valued for its ability to provide effective pain control with fewer effects on the heart compared to some other local anesthetics.
sourced from the EU Clinical Trials Register and site verification
Want to learn more about this trial or check if you can participate?
Tell us about your condition – we search every trial in Europe and connect you with the right site.